Cell Death in Leishmania donovani promastigotes in response to Mammalian Aurora Kinase B Inhibitor- Hesperadin (2024)
Attributed to:
Patient-centric supramolecular formulations of new anti-leishmanial drugs for Indian Communities
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2024.116960
PubMed Identifier: 38936193
Publication URI: http://europepmc.org/abstract/MED/38936193
Type: Journal Article/Review
Parent Publication: Biomedicine & Pharmacotherapy
ISSN: 0753-3322